United States · FDA National Drug Code directory
Diprivan
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 63323-269_645ea9e5-c2f5-40ef-85cd-3c1b5d8d0f27
- Product NDC
- 63323-269
- Form
- INJECTION, EMULSION
- Composition / generic term
- PROPOFOL
- Labeler
- Fresenius Kabi USA, LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20091113
- Source listing expiry
- 20261231
Source-listed ingredients
- PROPOFOL — 10 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 20 VIAL in 1 BOX (63323-269-59) / 50 mL in 1 VIAL (63323-269-45) · 63323-269-59
- 10 VIAL in 1 BOX (63323-269-69) / 100 mL in 1 VIAL (63323-269-41) · 63323-269-69
- 10 VIAL in 1 BOX (63323-269-94) / 20 mL in 1 VIAL (63323-269-43) · 63323-269-94
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →